KURSSIT JA MARKKINAT / UUTISET

Form 8.3 - [Abbvie. Inc]

24.01.2020 klo 16:25 Form 8.3 - [Abbvie. Inc]

                FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) State Street Global Advisors & Affiliates Company dealt in AbbVie Inc. Class of relevant security to which
the dealings being disclosed relate (Note 2) US$0.01 common stock Date of dealing 23rd January 2020

     

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

  Long Short   Number (%) Number (%) (1) Relevant securities 69,161,359

 

 

 

 

 

 

 

 

 

  4.67650%

 

 

 

 

 

 

 

 

 

 

 

      (2) Derivatives (other than options) N/A       (3) Options and agreements to
purchase/sell N/A       Total 69,161,359

 

 

 

 

 

 

 

 

 

  4.67650%

 

 

 

 

 

 

 

 

 

 

 

     

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short   Number (%) Number (%) (1) Relevant securities N/A       (2) Derivatives (other than options) N/A       (3) Options and agreements to purchase/sell N/A       Total N/A      

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit (Note 5) Purchase 600 85.27 Purchase 81 85.51 Purchase 174 85.40 Purchase 2,142 85.27 Purchase 73,870 85.27 Purchase 23,820 85.27 Purchase 43,670 85.27 Purchase 232 85.27 Purchase 768 85.27 Purchase 5,748 85.27 Purchase 225 85.27 Purchase 560 85.27 Purchase 560 85.27 Sale 800 85.25 Sale 10,900 85.27 Sale 22,512 85.27 Sale 105 85.27 Sale 11,800 85.27 Sale 2,988 85.38 Sale 7,784 85.27

 (b) Derivatives transactions (other than options transactions)

Product name,
e.g. CFD Nature of transaction

(Note 6) Number of relevant securities

(Note 7) Price per unit

(Note 5) N/A      

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,
e.g. call option Writing, selling,
purchasing
 varying etc. Number of
securities to which
the option relates
(Note 7) Exercise
price Type, e.g.
American,
European etc. Expiry
date Option money
paid/received
per unit (Note 5) N/A            

(ii) Exercising

Product name,
e.g. call option Number of securities Exercise price per
unit (Note 5) N/A    

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction
(Note 8) Details Price per unit
(if applicable) (Note 5) N/A    

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. N/A


Is a Supplemental Form 8 attached? (Note 9) NO


Date of disclosure 24th January 2020

  Contact name Lionel Colaco Telephone number                                                             020 33956098 If a connected EFM, name of offeree/offeror with which connected N/A If a connected EFM, state nature of connection (Note 10) N/A

GlobeNewswire